In a mouse model of NASH, STING deficiency attenuated steatosis, fibrosis, and inflammation in the liver; exposure to a STING agonist led to hepatic steatosis and inflammation in WT mice but not in STING-deficient mice (Yu et al., 2018). This evidence concerns the gene STING1 and Hepatic steatosis.